| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/22/2004 | US20040014213 Selected cell delivery for heart failure |
| 01/22/2004 | US20040014212 Culturing pancreatic tissues for treatment of diabetes; animal models; tissue engineering |
| 01/22/2004 | US20040014210 Stimulating conversion of progenitor cells into neuronal cells for treatment of nervous system and spinal cord disorders; tissue engineering |
| 01/22/2004 | US20040014206 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 01/22/2004 | US20040014188 Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same |
| 01/22/2004 | US20040014187 Comprises genetically engineered protease for treatment tumors; gene therapy |
| 01/22/2004 | US20040014178 Von willebrand factor-binding proteins from staphylococci |
| 01/22/2004 | US20040013740 Antitumor agents for treating tumor of mucosa, skin; poisons are selected from scolopenders, snakes, spiders or scorpions |
| 01/22/2004 | US20040013707 Alertness bar |
| 01/22/2004 | US20040013706 Stress and radiation resistance; antiallergens; antiinflammatory agents |
| 01/22/2004 | US20040013676 Administering dosage of mature dendritic cells in carrier |
| 01/22/2004 | US20040013668 Polypeptide antibody which binds to low density lipoprotein; quantitative analysis |
| 01/22/2004 | US20040013656 Fermentation soybean milk |
| 01/22/2004 | US20040013652 Incotinence; gastrointestinal refluxing; repairing tissue |
| 01/22/2004 | US20040013648 Vector system |
| 01/22/2004 | US20040013645 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/22/2004 | US20040013641 Disease prevention by reactivation of the thymus |
| 01/22/2004 | CA2843044A1 A process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid |
| 01/22/2004 | CA2833808A1 A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
| 01/22/2004 | CA2800113A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 01/22/2004 | CA2494245A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 01/22/2004 | CA2493871A1 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 01/22/2004 | CA2492720A1 A process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid |
| 01/22/2004 | CA2492601A1 Methods for inducing differentiation of embryonic stem cells and uses thereof |
| 01/22/2004 | CA2492383A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 01/22/2004 | CA2492029A1 Transdermal botulinum toxin compositions |
| 01/22/2004 | CA2489203A1 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 01/22/2004 | CA2489084A1 A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
| 01/21/2004 | EP1382672A1 Small liver cell-rich colony, method of preparing the same, method of maturing the same into liver tissue and method of estimating drug function using the matured small liver cell-rich colony |
| 01/21/2004 | EP1382616A2 Pharmaceutical composition for use in the treatment of abnormalities associated with the activity of a human Y5-receptor |
| 01/21/2004 | EP1382361A1 Unit for the selective removal of leucocytes from a platelet product |
| 01/21/2004 | EP1382346A1 Conditioned medium and diffusible biological product produced by incubating entrapped cells |
| 01/21/2004 | EP1381686A2 Inactivation of genes of the mep pathway |
| 01/21/2004 | EP1381674A2 Method for generating highly active human dendritic cells from monocytes |
| 01/21/2004 | EP1381622A2 Human secreted proteins |
| 01/21/2004 | EP1381410A2 Methods of isolating blood components using a centrifuge and uses thereof |
| 01/21/2004 | EP1381393A1 Microparticle protection of therapeutic agents |
| 01/21/2004 | EP1381389A1 Smallpox vaccine |
| 01/21/2004 | EP1381387A2 Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases |
| 01/21/2004 | EP1381345A2 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins |
| 01/21/2004 | EP1381280A1 Viral vectors and their use in therapeutic methods |
| 01/21/2004 | EP1381276A2 Method of treating or retarding the development of blindness |
| 01/21/2004 | EP1381274A1 Flexible container system for storage of stabilized hemoglobin solutions |
| 01/21/2004 | EP1242129B1 Biological joint construct |
| 01/21/2004 | EP1165573B1 Compounds selectively inhibiting gamma 9 delta 2 t lymphocytes |
| 01/21/2004 | EP0734263B1 ALPHAvBETA3 INTEGRIN AS A PREDICTOR OF ENDOMETRIOSIS |
| 01/21/2004 | CN1469923A Method of extensive culture of antigen-specific cytotoxic T cells |
| 01/21/2004 | CN1469750A Bone metabolism improving agent |
| 01/21/2004 | CN1469736A Use of a porous carrier |
| 01/21/2004 | CN1468956A Recombinant virus of antibody for high-efficiency expression to treat tumor and its use |
| 01/21/2004 | CN1468632A Growth hormone for ovarian functional cell and is prepn |
| 01/21/2004 | CN1468631A Prepn of protein-eliminating pregnant mare blood extractive |
| 01/21/2004 | CN1468608A Chinese medicine for treating hyperosteogeny |
| 01/21/2004 | CN1468605A Prepn of secondary fungus metabolite for promoting intestinal motive force |
| 01/21/2004 | CN1468604A Hydrolyzed pearl powder and its prepn process and use |
| 01/21/2004 | CN1135110C Oil preparation for treating burn and scald |
| 01/21/2004 | CN1135107C Chinese herb medicine for treating cardiovescular diseases and its preparing method thereof |
| 01/21/2004 | CN1135106C Chinese herb medicine for treating cerebral apoplexia and its preparing method |
| 01/20/2004 | US6680372 Antibodies specific for growth differentiation factor-7 |
| 01/20/2004 | US6680294 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 01/20/2004 | US6680198 Engraftable human neural stem cells |
| 01/20/2004 | US6680197 Breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, and t cells that are specific for cells expressing such polypeptides. |
| 01/20/2004 | US6680074 Potent antiviral, antibacterial or antimycotic activity |
| 01/20/2004 | US6680062 Anti-irritating rosacea treatment |
| 01/20/2004 | US6680060 A live hepatitis a virus adapted to growth in mrc-5 cells (human fibroblast-like cell line) |
| 01/20/2004 | US6680056 Stimulating proliferation of cytolytic t cells |
| 01/20/2004 | CA2241247C Archaeosomes, archaeosomes containing coenzyme q10, and other types of liposomes containing coenzyme q10 as adjuvants and as delivery vehicles |
| 01/20/2004 | CA2165984C Compounds for the photodecontamination of pathogens in blood |
| 01/20/2004 | CA2078235C Idiotypic vaccination against b cell lymphoma |
| 01/15/2004 | WO2004005531A2 Targeting and tracking of cells to specific organs and tissues in vivo |
| 01/15/2004 | WO2004005511A1 Tumor-lysing virus growing selectively in tumor cells |
| 01/15/2004 | WO2004005494A1 Medium for culturing autologous human progenitor stem cells and applications thereof |
| 01/15/2004 | WO2004005492A2 Probiotic compound on the basis of enterococcus faecium strain l-3 for medical-prophylactic means and method of production thereof |
| 01/15/2004 | WO2004005488A2 Replacing liver cells with bone marrow-derived cells for treating disease and expressing therapeutic genes |
| 01/15/2004 | WO2004004747A1 Antiflatulent composition, antiflatulent healthy drink and large intestine inside wash fluid |
| 01/15/2004 | WO2004004705A2 Pharmaceutical formulations for preparing drink products |
| 01/15/2004 | WO2004004663A2 Compositions and methods for ligament growth and repair |
| 01/15/2004 | WO2004004599A2 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 01/15/2004 | WO2003087337A3 Vascularized human skin equivalent |
| 01/15/2004 | WO2003078592A3 Method for the purification, production and formulation of oncolytic adenoviruses |
| 01/15/2004 | WO2003072728A3 Cellular trans-differentiation |
| 01/15/2004 | WO2003063786A3 Methods and composition for delivering nucleic acids and/or proteins to the respiratory system |
| 01/15/2004 | WO2003055992A3 A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 01/15/2004 | WO2003050271A3 In vitro production of dendritic cells from cd14+ monocytes |
| 01/15/2004 | WO2003004620A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/15/2004 | WO2002078526A3 Cancer-testis antigens |
| 01/15/2004 | US20040010814 Comprises nucleotide sequences coding kinases for developing contraceptives and controlling sex determination in animals |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/15/2004 | US20040010231 Deployment system for myocardial cellular material |
| 01/15/2004 | US20040010134 Albumin fusion proteins |
| 01/15/2004 | US20040009937 Intranasal administration of an immunogenic composition of a microflora organism having an expression vector wherein said expression vector comprises a heterologous nucleic acid that encodes for an antigen. |
| 01/15/2004 | US20040009604 Plasmid which codes envelop fusogenic membrane protein for treating cell proliferative disorders; antitumor agents; immunotherapy; gene therapy |
| 01/15/2004 | US20040009603 Antiviral vectors |
| 01/15/2004 | US20040009596 Extract from an Indian green mussel (perna viridis) for differentiation and maturation of dendric cells |
| 01/15/2004 | US20040009595 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 01/15/2004 | US20040009594 Propagating cytotoxic t lymphocytes from hemopoietic stem cells and using them for treating cancer; immunotherapy |
| 01/15/2004 | US20040009593 Differentiated cell population which generate glial cells for treating central nervous system traumas and disorders |
| 01/15/2004 | US20040009592 Genetically-modified neural progenitors and uses thereof |
| 01/15/2004 | US20040009591 Keratinocytes expressing exogenous angiogenic growth factors |
| 01/15/2004 | US20040009590 Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering |